Oranda Therapeutics Limited

Oranda Therapeutics is an innovative Irish startup rare disease biopharmaceutical company focused on accelerating patient access to innovative therapies with high unmet medical need. The company combines deep expertise in European market access, pricing and reimbursement strategy, and commercial execution to acquire, in-license and commercialise both established and late-stage rare disease medicines across Europe, the Middle East and Africa. Oranda’s agile commercial model and experienced leadership team are positioned to deliver near-term launches while expanding access for underserved patient populations and driving value for shareholders.